Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
A Black Box warning is the highest safety-related warning that medications can have assigned by the Food and Drug Administration.
FDA Warning: serious adverse reactions including tendinitis, tendon rupture, peripheral neuropathy, central nervous system damage, mental health issues, serious low blood sugar, risk of ruptures or tears in the aorta and exacerbation of myasthenia gravis
___________________________________________________________________________________________________
FDA Levaquin Label 06/28/2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020634s069lbl.pdf#page=51
FDA Cipro Label 05/03/2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019537s089,020780s046lbl.pdf#page=38
FDA Avelox 05/03/2019
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021085s065,021277s061lbl.pdf#page=33
FDA Press Release 2016:
https://www.fda.gov/news-events/press-announcements/fda-updates-warnings-Fluoroquinolone-antibiotics
Label Changes 2013:
Risk for possible permanent nerve damage
https://wayback.archive-it.org/7993/20170112031629/http:/www.fda.gov/Drugs/DrugSafety/ucm365050.htm
FDA Black Box Warning added in 2008:
Fluoroquinolones are associated with an increased risk of tendinitis and tendon rupture
Multiple FDA Warnings & Articles:
https://www.fda.gov/search?s=+Fluoroquinolone&sort_bef_combine=rel_DESC
In 2015, after victim testimonies before the Antimicrobial Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the FDA, a cluster of recognized symptoms became known as FQAD (Fluoroquinolone Associated Disability). The CDC has yet to recognize FQAD. Please note these symptoms do not include many of the severe common adverse effects continually reported in support groups by thousands living with this toxicity and yet to be fully acknowledged by any government entity.
It is crucial that patients or doctors witnessing adverse effects file a report to the FDA. If you don't report it, this condition is deemed rare. You may file a report each year you continue to experience issues: https://www.fda.gov/safety/report-problem-fda
Your support will help fund current and future research
On your Zelle account, copy and paste our email address to transfer your donation to our foundation: fq100@protonmail.com
Copyright © 2020 - All Rights Reserved.
Powered by GoDaddy Website Builder